advance iv results: efficacy and safety of intravenous efgartigimod in adults with primary itp
Published 1 year ago • 225 plays • Length 5:45Download video MP4
Download video MP3
Similar videos
-
0:52
insights from advance iv study: efgartigimod increases platelet counts of patients with itp
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
2:09
advances in the management of fit adults with aml
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
2:50
beacon trial results: safety & efficacy of bitopertin in adults with epp
-
6:24
indiko biochemistry analyzer demonstration
-
8:27
hdi™ pre procedure functions
-
2:34
advanced anoxomat iii
-
1:59
real-world outcomes of ide-cel in heavily pre-treated r/r mm
-
1:22
safety and efficacy of ari0002h for r/r mm
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
2:41
an overview of the latest advances in hematology
-
3:17
advances in gluten testing
-
2:34
ruby & edithal trials: evaluating the safety and efficacy of edit-301 in scd & thalassemia
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
4:48
an insight into the management of cytopenias in mf
-
2:43
the management of advanced phase mpns
-
0:45
difference between quality of life & patient-reported outcomes
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
2:25
key ebmt guideline updates for the treatment and prophylaxis of gvhd
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
3:13
targeting cd38 with a bispecific antibody to treat r/r aml: a phase i trial